Literature DB >> 2518682

Cost of antihypertensive treatment: a point of view from India.

H K Bali1, I S Anand.   

Abstract

In India, expenditure on the treatment of all patients with mild hypertension is not cost effective. Nonpharmacologic treatment is encouraged.

Entities:  

Mesh：

Year:  1989        PMID： 2518682     DOI： 10.1007/bf01857628

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


  29 in total

1.  Blood pressure studies in the adult population of Agra, India.

Authors:  K MATHUR; P N WAHI; D GAHLAUT
Journal:  Am J Cardiol       Date:  1963-01       Impact factor: 2.778

2.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

3.  Alternatives to traditional antihypertensive therapy.

Authors:  R M Zusman
Journal:  Hypertension       Date:  1986-10       Impact factor: 10.190

4.  A long-term follow-up of patients with essential hypertension treated with captopril.

Authors:  P Ohman; M Aurell; J Asplund; T Conradsson; K Delin; T Forslund; F Fyhrquist; G Frithz; H Herlitz; B Karlberg
Journal:  Acta Med Scand       Date:  1984

5.  Cardiovascular outcomes of treating high blood pressure.

Authors:  M A Weber
Journal:  Am Heart J       Date:  1987-10       Impact factor: 4.749

6.  Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.

Authors:  M H Weinberger
Journal:  Arch Intern Med       Date:  1985-06

7.  Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment.

Authors:  P J Lewis; E M Kohner; A Petrie; C T Dollery
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

8.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Financial cost as an obstacle to hypertension therapy.

Authors:  N B Shulman; B Martinez; D Brogan; A A Carr; C G Miles
Journal:  Am J Public Health       Date:  1986-09       Impact factor: 9.308

10.  Effects of labelling on income, work and social function among hypertensive employees.

Authors:  M E Johnston; E S Gibson; C W Terry; R B Haynes; D W Taylor; A Gafni; J I Sicurella; D L Sackett
Journal:  J Chronic Dis       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.